Sign in

    Sidharth Sahoo

    Research Analyst at HSBC

    Sidharth Sahoo is an Equity Research Analyst at HSBC, with a focus on healthcare companies such as UnitedHealth Group, Align Technology, and BrightSpring Health. He has covered 8 stocks with a demonstrated 45.45% success rate and has issued notable calls including downgrades and initiations with performance metrics like a 229.5% return on Align Technology and triple-digit returns on UnitedHealth Group. Sahoo began his current role at HSBC India prior to 2023 and has continued to build his coverage and performance track record since. He holds relevant professional credentials for equity research analysts and is recognized for his analytical coverage of major healthcare firms.

    Sidharth Sahoo's questions to Zoetis (ZTS) leadership

    Sidharth Sahoo's questions to Zoetis (ZTS) leadership • Q2 2025

    Question

    Sidharth Sahoo asked for the current growth expectation for the OA Pain franchise in the second half and inquired about the long-term strategy for driving bottom-line growth as the portfolio matures.

    Answer

    EVP & CFO Wetteny Joseph reiterated that the combined key franchises (Derm, Simparica, OA Pain) are still expected to grow double-digits for the full year, but declined to provide specific product-level guidance. He countered the idea of a 'maturing' portfolio, stating that addressable markets remain larger than currently served markets, offering ample growth. He affirmed that disciplined cost management is standard business practice to fund innovation.

    Ask Fintool Equity Research AI